Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000672788 | SCV000797930 | pathogenic | Fanconi anemia complementation group A | 2018-02-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001855583 | SCV002162805 | pathogenic | Fanconi anemia | 2023-08-18 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 556740). For these reasons, this variant has been classified as Pathogenic. This premature translational stop signal has been observed in individual(s) with fanconi anemia (PMID: 15643609, 29098742). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.His1272Thrfs*6) in the FANCA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FANCA are known to be pathogenic (PMID: 19367192). |
Fulgent Genetics, |
RCV000672788 | SCV002809825 | pathogenic | Fanconi anemia complementation group A | 2021-09-09 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000672788 | SCV004196605 | pathogenic | Fanconi anemia complementation group A | 2024-03-20 | criteria provided, single submitter | clinical testing | |
Leiden Open Variation Database | RCV000672788 | SCV001425998 | pathogenic | Fanconi anemia complementation group A | 2020-02-28 | no assertion criteria provided | curation | Curator: Arleen D. Auerbach. Submitter to LOVD: Arleen D. Auerbach. |